This topic contains a solution. Click here to go to the answer

Author Question: A patient is being treated with caspofungin for a systemic fungal infection related to Aspergillus. ... (Read 47 times)

biggirl4568

  • Hero Member
  • *****
  • Posts: 551
A patient is being treated with caspofungin for a systemic fungal infection related to Aspergillus. Prior to the administration of the first parenteral dose, the nurse notes that the patient's AST and ALT levels are elevated.
 
  How will these serum hepatic enzymes affect the administration of caspofungin?
  A) The dose will need to be increased.
  B) The dose will need to be decreased.
  C) The dose will require a serum trough.
  D) The medication should not be given.

Question 2

A patient presents with severe headache and pain in the effected sinus area. The nurse suspects the patient has _________________.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jayson

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

B

Answer to Question 2

Rhinitis




biggirl4568

  • Member
  • Posts: 551
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


adf223

  • Member
  • Posts: 304
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

As the western states of America were settled, pioneers often had to drink rancid water from ponds and other sources. This often resulted in chronic diarrhea, causing many cases of dehydration and death that could have been avoided if clean water had been available.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library